» Articles » PMID: 18317150

Nonsurgical Treatment of Cicatricial Ectropion with Hyaluronic Acid Filler

Overview
Specialty General Surgery
Date 2008 Mar 5
PMID 18317150
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cicatricial lower eyelid ectropion is caused by a shortening of the anterior lamella, with resultant eversion of the eyelid away from the globe. Treatment is typically surgical; however, the author hypothesized that a nonsurgical injection of hyaluronic acid filler could stretch the tethered skin and act as a tissue expander to correct the lid.

Methods: Fifteen patients with lower eyelid cicatricial ectropion were injected with a hyaluronic acid filler below the surface of the affected eyelid skin. The patients were followed prospectively for over 1 year for outcomes and complications.

Results: All patients achieved immediate and dramatic correction of their ectropion with a single injection. Eleven patients (73 percent) had complete correction lasting more than 1 year and four had partial correction. No major complications were observed; however, temporary bruising and a Tyndall effect was evident in a majority of patients.

Conclusions: Hyaluronic acid filler injections can successfully treat cicatricial ectropion by expanding the tethered anterior lamella of the skin. This provides an effective alternative to surgical correction of the lid. The treatment is quick, safe, and easy to learn.

Citing Articles

Nonsurgical management of upper eyelid retraction in thyroid eye disease.

Young S, Kim Y, Woo K Taiwan J Ophthalmol. 2025; 14(4):548-553.

PMID: 39803393 PMC: 11717341. DOI: 10.4103/tjo.TJO-D-23-00043.


Enhancing aesthetic outcomes: The role of biomechanics in periorbital and eyelid cosmetic surgery.

Guo L, Song B Indian J Ophthalmol. 2024; 72(10):1424-1432.

PMID: 39331432 PMC: 11573038. DOI: 10.4103/IJO.IJO_1549_23.


Short-term qualitative and quantitative analyses of preseptal injection of hyaluronic acid on the treatment of acquired lower eyelid cicatricial ectropion.

Veloso L, Ferreira G, Marques J, Meneghim R, Galindo A, Padovani C Arq Bras Oftalmol. 2024; 87(5):e20220245.

PMID: 39298732 PMC: 11626732. DOI: 10.5935/0004-2749.2022-0245.


The Posthyaluronidase Syndrome: Dosing Strategies for Hyaluronidase in the Dissolving of Facial Filler and Independent Predictors of Poor Outcomes.

Wilde C, Jiang K, Lee S, Ezra D Plast Reconstr Surg Glob Open. 2024; 12(4):e5765.

PMID: 38655103 PMC: 11037726. DOI: 10.1097/GOX.0000000000005765.


Infraorbital Hollow Rejuvenation: Considerations, Complications, and the Contributions of Midface Volumization.

Woodward J, Cox S, Kato K, Urdiales-Galvez F, Boyd C, Ashourian N Aesthet Surg J Open Forum. 2023; 5:ojad016.

PMID: 36998744 PMC: 10045888. DOI: 10.1093/asjof/ojad016.